Goldman Sachs’s Rennova Health, Inc. RNVA Stock Holding History

Goldman Sachs’s Portfolio RNVA Stock Details RNVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-3	Closed	-$14K	–	7573
2015 Q1	$14K	Buy	+3	New	+$15.6K	﹤0.01%	6945

Other funds holding RNVA

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

JMPWA

JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs's RNVA Position: Q2 2015 in Review

Goldman Sachs sold out of Rennova Health, Inc. (RNVA) in Q2 2015, closing a stake of 3 shares — an estimated $14K sold.

Goldman Sachs first reported a position in RNVA in Q1 2015 and held it in 1 quarter. The position peaked at $14K in Q1 2015. 9 funds tracked by Wall St. Rank hold RNVA as of Q2 2015.

Goldman Sachs reported no remaining Rennova Health, Inc. position as of Q2 2015 after selling out during the quarter.
Goldman Sachs sold 3 Rennova Health, Inc. shares in Q2 2015, an estimated $14K.
Goldman Sachs first reported a position in Rennova Health, Inc. in Q1 2015 and held it in 1 quarter.
Goldman Sachs's Rennova Health, Inc. position peaked at $14K in Q1 2015.
9 funds tracked by Wall St. Rank held Rennova Health, Inc. as of Q2 2015.

Based on Goldman Sachs's 13F filing for Q2 2015, filed 14 Aug 2015.